Loading...

Search Results (326)

MatchTypeWhy
Siegel, DavidPerson Why?
Managing adverse events of multiple myeloma and anti-multiple myeloma treatment: a perspective on carfilzomib.Academic Article Why?
Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group.Academic Article Why?
CD38 Monoclonal Antibody Therapies for Multiple Myeloma.Academic Article Why?
Subepithelial corneal immunoglobulin deposition as a manifestation of multiple myeloma: a case report and literature review.Academic Article Why?
Pretransplant induction regimens for multiple myeloma.Academic Article Why?
A phase 2 study of bortezomib in relapsed, refractory myeloma.Academic Article Why?
Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma.Academic Article Why?
Gastrointestinal amyloidosis and multiple myeloma.Academic Article Why?
Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America.Academic Article Why?
Novel therapeutic targets for multiple myeloma.Academic Article Why?
Pulmonary and nodal multiple myeloma mimicking lymphoma.Academic Article Why?
Therapeutic strategies for the treatment of multiple myeloma.Academic Article Why?
Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients.Academic Article Why?
Delineating the mTOR kinase pathway using a dual TORC1/2 inhibitor, AZD8055, in multiple myeloma.Academic Article Why?
Per Page    Page  of 22 Next
Prev
Search Criteria
  • myeloma
Search Result Filters
Back to TOP